CRT vs EQNR

The deterministic health profile is weak, highlighted by a Piotroski F-Score of 2/9, indicating significant deterioration in financial fundamentals. The stock is severely overvalued relative to its Graham Number ($2.46) and Intrinsic Value ($8.96), trading at an unsustainable Price-to-Book ratio of 29.50. While the company exhibits high profit margins typical of royalty trusts, the 100% dividend payout ratio leaves no margin for error. Combined with a highly bearish technical trend (10/100), the risk-reward profile is unfavorable.

Equinor exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is currently trading at a severe premium to its deterministic value. The current price of $37.94 is more than double the Graham Number ($18.78) and nearly triple the growth-based intrinsic value ($13.58). This valuation gap is compounded by sharply negative growth metrics, including a 27.3% YoY decline in earnings and a 0/100 bearish technical trend. While the balance sheet is healthier than the sector average, the combination of valuation overshoot and deteriorating fundamentals suggests significant downside risk.